Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Shinohara, Ayaka*; Hanaoka, Hirofumi*; Sakashita, Tetsuya*; Sato, Tatsuhiko; Yamaguchi, Aiko*; Ishioka, Noriko*; Tsushima, Yoshito*
Annals of Nuclear Medicine, 32(2), p.114 - 122, 2018/02
Times Cited Count：7 Percentile：37.8(Radiology, Nuclear Medicine & Medical Imaging)Radionuclide therapy with low-energy auger electron emitters could potentially provide high anti-tumor efficacy while keeping normal organs toxicity low. In this study, we evaluated the usefulness of auger electron emitter 
I and compared it with beta-emitter 
I for tumor treatment in 2D and 3D cell culture models. The computer simulation model for 2D and 3D cell culture were constructed, and the absorbed radiation dose of I or I in each model were calculated by using a Monte Carlo simulation code (PHITS). The therapeutic effect of I was comparable to that of I in 2D model, but the efficacy was inferior to that of I-MIBG in 3D model, since crossfire effect is negligible and the homogeneous distribution of radionuclide was insufficient.
Br-
-methyl-phenylalanine for tumor PET imagingHanaoka, Hirofumi*; Ohshima, Yasuhiro; Suzuki, Yurika*; Yamaguchi, Aiko*; Watanabe, Shigeki; Uehara, Tomoya*; Nagamori, Shushi*; Kanai, Yoshikatsu*; Ishioka, Noriko; Tsushima, Yoshito*; et al.
Journal of Nuclear Medicine, 56(5), p.791 - 797, 2015/05
Times Cited Count：17 Percentile：60.45(Radiology, Nuclear Medicine & Medical Imaging)Ohshima, Yasuhiro; Tsushima, Yoshito*
Hoshasen To Sangyo, (136), p.9 - 12, 2014/06
no abstracts in English
-methyltyrosine (FAMT) uptake on PET in patients with oesophageal cancerSuzuki, Shigemasa*; Kaira, Kyoichi*; Ohshima, Yasuhiro; Ishioka, Noriko; Soda, Makoto*; Yokobori, Takehiko*; Miyazaki, Tatsuya*; Oriuchi, Noboru*; Tominaga, Hideyuki*; Kanai, Yoshikatsu*; et al.
British Journal of Cancer, 110(8), p.1985 - 1991, 2014/04
Times Cited Count：23 Percentile：60.46(Oncology)
F]fluoro--methyl-D-tyrosine (D-[F]FAMT) as a novel amino acid tracer for positron emission tomographyOhshima, Yasuhiro; Hanaoka, Hirofumi*; Tominaga, Hideyuki*; Kanai, Yoshikatsu*; Kaira, Kyoichi*; Yamaguchi, Aiko*; Nagamori, Shushi*; Oriuchi, Noboru*; Tsushima, Yoshito*; Endo, Keigo*; et al.
Annals of Nuclear Medicine, 27(4), p.314 - 324, 2013/05
Times Cited Count：14 Percentile：49.06(Radiology, Nuclear Medicine & Medical Imaging)F]fluoro--methyl-D-tyrosine (D-[F]FAMT) as a novel amino acid tracer for positron emission tomographyOhshima, Yasuhiro; Hanaoka, Hirofumi*; Tominaga, Hideyuki*; Kanai, Yoshikatsu*; Kaira, Kyoichi*; Yamaguchi, Aiko*; Nagamori, Shushi*; Oriuchi, Noboru*; Tsushima, Yoshito*; Endo, Keigo*; et al.
no journal, ,
no abstracts in English
F]fluoro--methyl-D-tyrosine (D-[F]FAMT) as a novel amino acid tracer for positron emission tomographyOhshima, Yasuhiro; Hanaoka, Hirofumi*; Tominaga, Hideyuki*; Kanai, Yoshikatsu*; Kaira, Kyoichi*; Yamaguchi, Aiko*; Nagamori, Shushi*; Oriuchi, Noboru*; Tsushima, Yoshito*; Endo, Keigo*; et al.
no journal, ,
Ohshima, Yasuhiro; Tsukimoto, Mitsutoshi*; Tsushima, Yoshito*; Ishioka, Noriko
no journal, ,
no abstracts in English
At]astato--methyl-L-phenylalanine (2-AAMP) as a novel radiopharmaceutical for internal radiotherapyOhshima, Yasuhiro; Suzuki, Hiroyuki*; Hanaoka, Hirofumi*; Watanabe, Shigeki; Watanabe, Satoshi; Watanabe, Naoyuki*; Tsushima, Yoshito*; Endo, Keigo*; Arano, Yasushi*; Ishioka, Noriko
no journal, ,
Br-bromo--methyl-L-phenylalanine as a novel Br-labeled PET tracerOhshima, Yasuhiro; Hanaoka, Hirofumi*; Suzuki, Yurika*; Yamaguchi, Aiko*; Watanabe, Shigeki; Uehara, Tomoya*; Nagamori, Shushi*; Kanai, Yoshikatsu*; Ishioka, Noriko; Tsushima, Yoshito*; et al.
no journal, ,
no abstracts in English
